Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > LifeSci Communications

<< Previous

Bullboard Posts

Next >>

Comment by Metalsguy1on May 17, 2022 12:57pm

94 Views

Post# 34689586

RE:RE:RE:RE:RE:RE:LifeSci Communications

Could not agree more MS. With all the rumors swirling for months, the expectations were for a deal that would put SVA on the map. Based on the response in the market it did, but only to map quest which nobody uses anymore. If we had been on the NASDQ we would likely have blown past 2 or 3 bucks.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages